AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
Harvard University · Massachusetts General Hospital · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,765
total citations
- FWCI
- 73.86
- Percentile
- 100%
- References
- 63
Citations per year
Authors
21- TTTracy T. BatchelorCorresponding
Harvard University, Massachusetts General Hospital, Mass General Brigham
- AGA. Gregory Sorensen
Harvard University, Massachusetts General Hospital, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts Institute of Technology
- EDEmmanuelle di Tomaso
Harvard University, Massachusetts General Hospital
- WZWei-Ting Zhang
Harvard University, Massachusetts General Hospital, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts Institute of Technology
- DGDan G. Duda
Harvard University, Massachusetts General Hospital
Topics & keywords
Topics
Keywords
- Tyrosine-kinase inhibitor
- Medicine
- Edema
- Cancer research
- Tyrosine kinase
- Receptor
- Internal medicine
- Receptor tyrosine kinase
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.